Author(s): Lima, Milena da Silva ; Quintans Júnior, Lucindo José ; Santana, Wagno Alcântara de ; Kaneto, Carla Martins ; Soares, Milena Botelho Pereira ; Villarreal, Cristiane Flora ; Lima, Milena da Silva ; Quintans Júnior, Lucindo José ; Santana, Wagno Alcântara de ; Kaneto, Carla Martins ; Soares, Milena Botelho Pereira ; Villarreal, Cristiane Flora
Date: 2013
Origin: Oasisbr
Subject(s): Carvacrol; Anti-inflammatory; Cytokines; Interleukin-10; PGE2
Texto completo. Acesso restrito. p. 112–117
Submitted by Santiago Fabio (fabio.ssantiago@hotmail.com) on 2013-07-08T13:16:49Z No. of bitstreams: 1 55555555555555.pdf: 611395 bytes, checksum: 24cfe10ac84d533e244253fe7d12fa1a (MD5)
Approved for entry into archive by Alda Lima da Silva(sivalda@ufba.br) on 2013-08-16T19:12:40Z (GMT) No. of bitstreams: 1 55555555555555.pdf: 611395 bytes, checksum: 24cfe10ac84d533e244253fe7d12fa1a (MD5)
Made available in DSpace on 2013-08-16T19:12:40Z (GMT). No. of bitstreams: 1 55555555555555.pdf: 611395 bytes, checksum: 24cfe10ac84d533e244253fe7d12fa1a (MD5) Previous issue date: 2013
Carvacrol, a phenolic monoterpene, has been reported to possess anti-inflammatory properties. However, the mechanisms involved in its pharmacological properties are currently not well understood. In the present study, the contribution of cytokine modulation to the anti-inflammatory effects of carvacrol was investigated in a classical inflammation model: the complete Freund’s adjuvant (CFA)-induced paw inflammation in mice. The paw edema was measured using a plesthismometer. Paw tissue was removed 2 h after the inflammatory stimulus to determine the levels of prostaglandin E2 (PGE2) by enzyme immunoassay, the levels of interleukin-1 β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-10 (IL-10) by ELISA or the mRNA expression of cyclooxygenase-2 (COX-2), IL-1β, TNF-α, and IL-10 by real-time PCR. Administration of carvacrol produced anti-inflammatory effects against CFA-induced inflammation in mice. Treatment of mice with carvacrol at 50 and 100 mg/kg attenuated the paw edema and reduced the IL-1β and PGE2, but not TNF-α, local levels. Similarly, carvacrol (100 mg/kg) reduced the COX-2 and IL-1β mRNA expression. The levels of IL-10, an anti-inflammatory cytokine, and the IL-10 mRNA expression in the inflamed paw were enhanced by carvacrol. In addition, the treatment with carvacrol did not reduce the CFA-induced paw edema in IL-10 knockout mice. The present results suggest that carvacrol causes anti-inflammatory effects by reducing the production of inflammatory mediators, such as IL-1β and prostanoids, possibly through the induction of IL-10 release.
Salvador
